Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
Ensign Group, Inc. (ENSG) Stock Analysis: Strong Growth and 10.84% Potential Upside Entice Investors 28 July 2025
Stevanato Group S.p.A. (STVN) Stock Analysis: A Healthcare Innovator with a 5.69% Upside Potential 28 July 2025
Option Care Health, Inc. (OPCH) Investor Outlook: Analyzing a 29.86% Potential Upside in the Healthcare Sector 28 July 2025
Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating Volatility and Future Prospects in the Healthcare Sector 28 July 2025
West Pharmaceutical Services, Inc. (WST): Investor Outlook on a Healthcare Giant with 19.54% Upside Potential 28 July 2025
TG Therapeutics, Inc. (TGTX): Analyst Consensus Highlights Promising Upside in Biotech Sector 28 July 2025
Medpace Holdings, Inc. (MEDP) Investor Outlook: Navigating the Growth Path Amidst Market Dynamics 28 July 2025
Moderna, Inc. (MRNA) Stock Analysis: Navigating Market Challenges with Innovation and Potential Upside 28 July 2025
Incyte Corporation (INCY) Stock Analysis: Navigating Growth in the Biotech Sector with a 7.42% Upside Potential 28 July 2025
Thermo Fisher Scientific Inc. (TMO) Stock Analysis: Exploring a 15% Upside Potential Amid Robust Revenue Growth 28 July 2025
DaVita Inc. (DVA) Stock Analysis: Unveiling a 10.56% Potential Upside in the Healthcare Sector 28 July 2025
Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with 13% Potential Upside 28 July 2025
Insmed Incorporated (INSM) Stock Analysis: Biotech’s 11.31% Potential Upside Captures Investor Attention 28 July 2025
Revolution Medicines, Inc. (RVMD) Investor Outlook: A 90% Upside Potential in the Precision Oncology Market 28 July 2025
Repligen Corporation (RGEN) Stock Analysis: Exploring a 47.59% Potential Upside in the Booming Bioprocessing Sector 28 July 2025
Hercules Plc Training 2,000 Workers to Help Solve the UK Infrastructure Skills Crisis (Video) 17 November 2025
Firering Strategic Minerals $1M Ricca Settlement Injects Momentum into Lithium Strategy (Video) 14 November 2025
ICG Enterprise Trust: Mid-Teen Growth and a Strong Pipeline Signal Resilience (Video) 11 November 2025
Record plc Transition Strategy Gains Traction as CEO Eyes Billion-Dollar Milestone (Video) 11 November 2025
Cizzle Biotechnology New NHS-Aligned Partnership Moves Lung Cancer Test Closer to UK Clinics (Video) 6 November 2025
Harbour Energy to acquire Waldorf subsidiaries in $170m deal, boosting UK production 12 December 2025
TwentyFour Income Fund reports positive month as ABS and CLO issuance hits post-crisis highs 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
